The use of methotrexate perioperatively in patients with rheumatoid arthritis undergoing major joint replacement surgery: Will we ever have consensus about its use?

Journal of Clinical Rheumatology

Volumn 2, Issue 1, 1996, Pages 6-8

  Alarcón, Graciela S ^a,f   Moreland, Larry W ^a   Jaffe, Kenneth ^b   Phillips, R Macon ^c   Bocanegra, Tomas ^d   Russell, I Jon ^e  

^a University of Alabama at Birmingham   (United States)

^b Kentucky   (United States)

^c Rheumatologists Inc of N Alabama   (United States)

^d UNIVERSITY OF SOUTH FLORIDA   (United States)

^e UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^f UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Arthroplasty; Methotrexate; Perioperative period; Rheumatoid arthritis

Indexed keywords

METHOTREXATE; PLACEBO;

ARTHROPLASTY; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DOSE RESPONSE; DRUG EFFICACY; HUMAN; MULTICENTER STUDY; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RHEUMATOID ARTHRITIS; SEPSIS; TREATMENT PLANNING; WOUND INFECTION;

EID: 0029955543     PISSN: 10761608     EISSN: None     Source Type: Journal    
DOI: 10.1097/00124743-199602000-00003     Document Type: Article

References (13)

1. Thompson RN, Watts C, Edelman J, Esdaile J, Russell AS. A controlled two-center trial of parenteral methotrexate therapy for refractory rheumatoid arthritis. J Rheumatol 1984;11: 760-763.
2. Weinblatt ME, Coblyn JS, Fox DA, et al. Efficacy of low-dose methotrexate in rheumatoid arthritis. New Engl J Med 1985;312:818-822.
3. Williams HJ, Willkens RF, Samuelson CO, Jr. et al. Comparison of low-dose oral pulse methotrexate and placebo in the treatment of rheumatoid arthritis: a controlled clinical trial. Arthritis Rheum 1985;28:721-730.
4. Andersen PA, West SG, O'Dell JR, Via CS, Claypool RG, Kotzin BL. Weekly pulse methotrexate in rheumatoid arthritis. Clinical and Immunologic effects in a randomized, double-blind study. Ann Intern Med 1985;103:489-496.
5. Alarcón GS, Tracy IC, Blackburn WD Jr. Methotrexate in rheumatoid arthritis: toxic effects as the major factor in limiting long-term treatment. Arthritis Rheum 1989;32:671-676.
6. Weinblatt ME, Weissman BN, Holdsworth DE, et al. Long-term prospective study of methotrexate in the treatment of rheumatoid arthritis. 84-month update. Arthritis Rheum 1992;35:129-137.
7. Kremer JM, Phelps CT. Long-term prospective study of the use of methotrexate in the treatment of rheumatoid arthritis. Update after a mean of 90 months. Arthritis Rheum 1992;35: 138-145.
8. Bridges SL, Jr., López-Méndez A, Tracy I, Alarcón GS. Should methotrexate be discontinued prior to total joint arthroplasty in patients with rheumatoid arthritis? (Abstract) Arthritis Rheum 1989;32:543.
9. López-Méndez A, Bridges SL Jr, Han KH, Tracy IC, Alarcón GS. Methotrexate increases risk of post-surgical complications in rheumatoid arthritis patients. (Abstract) Arthritis Rheum 1990;33:R13.
10. Bridges SL Jr, López-Méndez A, Han KH, Tracy I, Alarcón GS. Should methotrexate be discontinued before elective orthopedic surgery in patients with rheumatoid arthritis? J Rheumatol 1991;18:984-988.
11. Perhala RS, Wilke WS, Clough JD, Segal AM. Local infectious complications following large joint replacement in rheumatoid arthritis patients treated with methotrexate versus those not treated with methotrexate. Arthritis Rheum 1991;34:146-152.
12. Sany J, Anaya, J-M, Canovas F, et al. Influence of methotrexate on the frequency of postoperative infectious complications in patients with rheumatoid arthritis. J Rheumatol 1993; 20:1129-1132.
13. Kasdan ML, June L. Postoperative results of rheumatoid arthritis patients on methotrexate at the time of reconstructive surgery of the hand. Orthopedics 1993;16:1233-1235.